Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Non-Current Assets (2016 - 2026)

Gyre Therapeutics has reported Non-Current Assets over the past 16 years, most recently at $63.8 million for Q4 2025.

  • Quarterly Non-Current Assets rose 5.18% to $63.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $247.3 million through Dec 2025, down 4.06% year-over-year, with the annual reading at $63.8 million for FY2025, 5.18% up from the prior year.
  • Non-Current Assets was $63.8 million for Q4 2025 at Gyre Therapeutics, up from $60.8 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $70.4 million in Q3 2024 and troughed at $773000.0 in Q3 2022.
  • The 5-year median for Non-Current Assets is $20.0 million (2021), against an average of $31.8 million.
  • Year-over-year, Non-Current Assets tumbled 83.1% in 2022 and then skyrocketed 1357.6% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $4.2 million in 2021, then surged by 738.51% to $35.1 million in 2022, then skyrocketed by 69.0% to $59.3 million in 2023, then increased by 2.19% to $60.6 million in 2024, then increased by 5.18% to $63.8 million in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Non-Current Assets are $63.8 million (Q4 2025), $60.8 million (Q3 2025), and $61.4 million (Q2 2025).